Latest News

Medtrade partners with Laubscher & Co to address postpartum haemorrhage across Switzerland

16th March 2023

Medtrade Products Ltd is delighted to announce that it has entered into an exclusive agreement with Laubscher & Co AG to distribute the revolutionary CELOX™ PPH Uterine Haemostatic Tamponade in Switzerland. CELOX™ PPH offers a unique, CE-certified solution for uterine postpartum haemorrhage (PPH), and Laubscher’s network of Swiss hospitals and...

read more

Medtrade partners with Laubscher & Co to address postpartum haemorrhage across Switzerland

16th March 2023

  Medtrade Products Ltd is delighted to announce that it has entered into an exclusive agreement with Laubscher & Co AG to distribute the revolutionary CELOX™ PPH Uterine Haemostatic Tamponade in Switzerland. CELOX PPH offers a unique, CE-certified solution for uterine postpartum haemorrhage (PPH), and Laubscher’s network of Swiss hospitals...

read more

Medtrade partners with Dahlhausen® Medizintechnik to reach maternity units across Germany and Austria

22nd February 2023

Medtrade Products Ltd is delighted to announce that it has entered into an exclusive agreement with Dahlhausen® Medizintechnik to distribute the revolutionary CELOX™ PPH Uterine Haemostatic Tamponade throughout Austria and Germany. CELOX™ PPH offers a unique, CE-certified solution for uterine postpartum haemorrhage (PPH), and Dahlhausen Medizintechnik’s extensive network will help...

read more

Medtrade partners with Dahlhausen® Medizintechnik to reach maternity units across Germany and Austria

22nd February 2023

Medtrade Products Ltd is delighted to announce that it has entered into an exclusive agreement with Dahlhausen® Medizintechnik to distribute the revolutionary CELOX™ PPH Uterine Haemostatic Tamponade throughout Austria and Germany. CELOX PPH offers a unique, CE-certified solution for uterine postpartum haemorrhage (PPH), and Dahlhausen Medizintechnik’s extensive network will help...

read more

Medtrade Products Ltd announces CE certification for a ground-breaking solution for the management of postpartum haemorrhage

7th November 2022

Medtrade Products Ltd is pleased to announce CE certification for its CELOX™ PPH Uterine Haemostatic Tamponade, a significant and  state-of-the-art innovation that provides rapid and effective control of postpartum bleeding, a prevalent and severe complication of childbirth. Gaining accreditation for this game-changing device is a significant medical milestone in the field...

read more

Medtrade Products Ltd announces CE certification for a ground-breaking solution for the management of postpartum haemorrhage

7th November 2022

Medtrade Products Ltd is pleased to announce CE certification for its CELOX™ PPH Uterine Haemostatic Tamponade, a significant and  state-of-the-art innovation that provides rapid and effective control of postpartum bleeding, a prevalent and severe complication of childbirth. Gaining accreditation for this game-changing device is a significant medical milestone in the field...

read more

CEO Russ Mably on Business Brunch with Des Machin – Cat Radio

7th July 2022

Russ Mably, our CEO of Medtrade and Celox Medical products, attended an interview on Cat Radio to proudly discuss the highlights of Medtrade and the support provided to the crisis in Ukraine. Medtrade mobilised rapidly reacting to the situation in Ukraine and is manufacturing around the clock to help support...

read more

CPJ and Medtrade to distribute CELOX lifesaving medical supplies in Ukraine

9th May 2022

New York, May 6, 2022 – As the war in Ukraine enters its third month, journalists facing increased risks in their daily reporting will receive lifesaving medical supplies through a new partnership between the Committee to Protect Journalists and the medical device company Medtrade, the manufacturer of CELOX Hemostatic Technology. The medical supplies,...

read more

MEDTRADE RECEIVES EU MDR CERTIFICATION FOR THE CELOX CE RANGE

17th March 2022

Medtrade Products Ltd are proud to announce the success of receiving the MDR certification for the CELOX CE range of devices alongside MDR Quality Management system certification from BSI. The EU MDR is a medical device regulation that affects all medical devices placed in the European market. Medtrade the parent company...

read more

Medtrade awarded innovation grant to develop next generation haemostatic technology

16th September 2021

Medtrade Products Ltd are proud to announce the successful award of an innovation and research project from the Medical Technology Enterprise Consortium (MTEC NCH – MTEC (mtec-sc.org). Despite fierce competition from numerous different companies, the U.S. Army Medical Material Development Activity (USAMMDA) selected Medtrade Products Ltd to create a product...

read more

Celox Rapid, The Hemostat That Works Even When Blood Doesn’t

11th December 2020

Despite significant developments in scientific understanding and technology, hemorrhage remains the leading cause of preventable trauma related deaths in civilian life and on the battlefield.1-3 The challenges medics face when treating a patient is being unaware of the patients internal conditions through, for example, the use of blood thinners. Another...

read more

Exploring military trauma in the Iraq war

25th February 2019

The conflict in Iraq, that began in 2003 and ran until 2011, is arguably one of the most divisive and controversial conflicts in recent memory. No matter how history ultimately looks upon the war, there are several lessons we can take from it, particularly in terms of trauma care in...

read more

Get In Touch

Get In Touch

Col 1

Col 2

Enquiry Type

Col 3

Made To Save Lives

CELOX Medical

Electra House,
Crewe Business Park,
Crewe,
UK,
CW1 6GL

OMNI-STAT Medical

New York – SoHo – Hudson Square,
101 Avenue of the Americas,
8th and 9th Floors,
New York, USA,
NY 10013

This website uses Cookies to improve your browsing experience and to help with our marketing. You can read more about removing Cookies here: Cookie Policy

I'm fine with this
Get In Touch

Get In Touch

We would like to hear from you. Please send us a message by filling out the form below and we will get back with you shortly.

Col 1

Col 2

Enquiry Type

Col 3